References
- Bakalov VK, Shawker T, Ceniceros I, et al. Uterine development in Turner syndrome. J Pediatr 2007;151:528–31
- Bannink EM, van Sassen C, van Buuren S, et al. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels. Clin Endocrinol 2009;70:265–73
- Bondy CA; Turner Syndrome Study Group. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 2007;92:10–25
- Hjerrild BE, Mortensen KH, Gravholt CH. Turner syndrome and clinical treatment. Br Med Bull 2008;86:77–93
- Doerr HG, Bettendorf M, Hauffa BP, et al. Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001. Hum Reprod 2005;20:1418–21
- Elsheikh M, Dunger DB, Conway GS, Wass AH. Turner’s Syndrome in adulthood. the endocrine society. Endocr Rev 2002;23:120–40
- Gravholt CH. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur J Endocrinol 2004;151:657–87
- Suzigan LZ, Silva RB, Maciel-Guerra AT. Aspectos psicossociais da síndrome de Turner. Arq Bras Endocrinol Metab 2005;49:157–64
- Haber HP, Ranke MB. Pelvic ultrasonography in Turner syndrome: standards for uterine and ovarian volume. J Ultrasound Med 1999;18:271–6
- Massarano AA, Adams JA, Preece MA, Brook CG. Ovarian ultrasound appearances in Turner syndrome. J Pediatr 1989;114:568–73
- Matarazzo P, Lala R, Artesani L, et al. Sonographic appearance of ovaries and gonadotropin secretions as prognostic tools of spontaneous puberty in girls with Turner’s syndrome. J Pediatr Endocrinol Metab 1995;8:267–74
- Mazzanti L, Cacciari E, Bergamaschi R, et al. Pelvic ultrasonography in patients with Turner syndrome: age-related findings in different karyotypes. J Pediatr 1997;131:135–40
- McDonnell CM, Coleman L, Zacharin MR. A 3-year prospective study to assess uterine growth in girls with Turner’s syndrome by pelvic ultrasound. Clin Endocrinol 2003;58:446–50
- Nabhan ZM, Dimeglio LA, Qi R, et al. Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study. J Clin Endocrinol Metab 2009;94:2009–1
- Pasquino AM, Passeri F, Pucarelli I, et al. Spontaneous pubertal development in Turner’s syndrome. Italian Study Group for Turner’s Syndrome. J Clin Endocrinol Metab 1997;82:1810–3
- Paterson WF, Hollman AS, Donaldson MD. Poor uterine development in Turner syndrome with oral oestrogen therapy. Clin Endocrinol 2002;56:359–65
- Hagen CP, Main KM, Kjaergaard S, et al. FSH, LH, inhibin B and estradiollevels in Turner syndrome depend on age and karyotype: longitudinal study of 70 Turner girls with or without spontaneous puberty. Hum Reprod 2010;25:3134–41
- Ribeiro PMM. Ultra-Sonografia Ginecologica in Tratado de Ginecologia FEBRASGO. Rio de Janeiro: Revinter; 2000:194–203
- Quigley CA, Crowe BJ, Anglin DG, Chipman JJ. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J Clin Endocrinol Metab 2002;87:2033–41
- Snajderova M, Mardesic T, Lebl J, et al. Czech National Study Group for HRT Optimization in Paediatric and Adolescent Endocrinology and Gynaecology. The uterine length in women with Turner syndrome reflects the postmenarcheal daily estrogen dose. Horm Res 2003;60:198–204
- Sybert VP, McCauley E. Turner’s syndrome. N Engl J Med 2004;351:1227–38
- Högler W, Briody J, Moore B, et al. Importance of estrogen on bone health in Turner Syndrome: a cross-sectional and longitudinal study using Dual-Energy X-Ray Absorptiometry. J Clin Endocrinol Metab 2004;89:193–9
- Blair J, Tolmie J, Hollman AS, Donaldson MD. Phenotype, ovarian function, and growth in patients with 45,X/47,XXX Turner mosaicism: implications for prenatal counseling and estrogen therapy at puberty. J Pediatr 2001;139:724–8 22